NCT04561297View on ClinicalTrials.gov

Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

TDC differential value

TDC measurements in all patients agreeing to participate who are scheduled for a biopsy of a breast tumor or mass

Trial Locations (1)

33180

Surgical Specialists of Miami, Aventura

All Listed Sponsors
collaborator

Surgical Specialists of Miami

UNKNOWN

lead

Nova Southeastern University

OTHER

NCT04561297 - Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts | Biotech Hunter | Biotech Hunter